Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2018, Vol. 45 Issue (1): 132-134    DOI: 10.12891/ceog3768.2018
Case Report Previous articles | Next articles
Microwave endometrial ablation may be an ineffective procedure for life-threatening uterine bleeding induced by an uterine arteriovenous malformation
K. Nakamura1, K. Nakayama1, *(), M. Ishikawa1, H. Katagiri1, T. Ishibashi1, E. Sato1, S. Kyo1
1 Department of Obstetrics and Gynecology, Shimane University School of Medicine, Izumo, Japan
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Microwave endometrial ablation (MEA) is effective for the emergent control of uterine hemorrhage. No cases involving life-threatening hemorrhage induced by a uterine arteriovenous malformation (UAVM) treated by MEA have been reported. In the current case, the authors evaluated the efficacy of MEA as a first-line therapeutic option for a bleeding UAVM; however, MEA was ineffective in controlling the bleeding induced by the UAVM. Given its safety, simplicity, and effectiveness, MEA has been widely adopted for the emergency control of uterine bleeding; however, MEA should be used with extreme caution for the treatment of intractable bleeding induced by uterine AVM. Although MEA is thought be a highly efficacious way to urgently control life-threatening uterine hemorrhage, MEA should be used for the treatment of UAVMs with extreme caution.
Key words:  MEA      UAVM      Life threatening uterine bleeding     
Published:  10 February 2018     
*Corresponding Author(s):  K. NAKAYAMA     E-mail:  kn88@med.shimane-u.ac.jp

Cite this article: 

K. Nakamura, K. Nakayama, M. Ishikawa, H. Katagiri, T. Ishibashi, E. Sato, S. Kyo. Microwave endometrial ablation may be an ineffective procedure for life-threatening uterine bleeding induced by an uterine arteriovenous malformation. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 132-134.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3768.2018     OR     https://ceog.imrpress.com/EN/Y2018/V45/I1/132

[1] Silvia Amodeo, Giulia Bonavina, Anna Seidenari, Paolo Ivo Cavoretto, Antonio Farina. Real-world implementation and adaptation to local settings of first trimester preeclampsia screening in Italy: a systematic review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 812-819.
[2] J.H. Check, D. Check, R. Cohen. A novel effective treatment for menière’s disease – dextroamphetamine sulfate[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 807-809.
[3] T. Cengiz, T. Toka Özer, F. Kılınç, R. Selimoğlu, H. Yılmaz. Candida albicans infection of cervix and comparison of Pap smear and culture in diagnosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 253-256.
[4] E. Kadour-Peero, S. Khoury, J. Awad, L. Shpritz, L. Chen-Konak, C. Shechner, L. Saiegh. Determination of estradiol and progesterone concentrations in human scalp hair[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 268-271.
[5] J.H. Check, D. Check. The increased cellular permeability syndrome manifesting as severe idiopathic type urinary incontinence[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 812-814.
[6] J.H. Check, R. Cohen. Sympathomimetic amine therapy abrogates severe long-term unexpalined abdominal pain and diarrhea (microscopic colitis) - possible infertility implications[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(3): 489-491.
[7] M. Hocaoglu, A. Turgut, E. Akdeniz, A. Usta, A.A. Ersahin, A. Karateke. Predictive value of neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and mean platelet volume for pelvic inflammatory disease[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 36-41.
[8] K. Sanuki, K. Nakayama, K. Nakamura, T. Ishibashi, M. Ishikawa, N. Ishikawa, S. Kyo. Rapidly enlarged uterus following microwave endometrial ablation: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 159-160.
[9] J.H. Check, M. Citerone, T. Citerone. The increased cellular permeability syndrome as a cause of traumatic stuttering[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 773-774.
[10] J.H. Check. Changing the name of a syndrome: sympathetic neural hyperalgesia edema syndrome becomes – the increased cellular permeability syndrome[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(6): 819-823.
[11] Ş. Özdeṁirci, T. Kasapoğlu, E. Karahanoğlu, F. Salgur, E. Başer, D. Esinler, B. Coşkun. Association of intrapartum maternal mean platelet volume with neonatal birth weight[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(4): 587-590.
[12] J. H. Check, R. Cohen. Marked improvement of severe gastroparesis following high dosage, but very well tolerated, dextroamphetamine sulfate[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(4): 611-612.
[13] Y. Cekmez, A. Göçmen, F. Şanlıkan, S. B. Türkmen. Role of mean platelet volume and neutrophil/lymphocyte ratio to predict single-dose methotrexate treatment success in tubal ectopic pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(4): 509-511.
[14] S. Hacivelioglu, A. Uysal, A.N. Cakir Gungor, M. Gencer, D.U. Cakir, E. Cosar. The effect of maternal polycystic ovary morphology on first-trimester maternal serum biochemical markers of aneuploidy and fetal nuchal translucency thickness[J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(1): 32-35.
[15] X.Y. He, H. Yao, Z.N. Ma. Investigation and analysis of contraceptive measures towards different reproductive-aged women in Yangzhou[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(6): 704-708.
No Suggested Reading articles found!